Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W J Elliott

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
Clinical Therapeutics|September 18, 2001
Losartan versus valsartan in the treatment of patients with mild to moderate essential hypertension: data from a multicenter, randomized, double-blind, 12-week trialW J Elliott, D A Calhoun, P T DeLucca, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 8, 2000
Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working GroupG L Bakris, M Williams, L Dworkin, et al.
Circulation|March 1, 1990
Renal and hemodynamic effects of intravenous fenoldopam versus nitroprusside in severe hypertensionW J Elliott, R R Weber, K S Nelson, et al.
Hypertension (Dallas, Tex. : 1979)|November 17, 2001
One-year study of felodipine or placebo for stage 1 isolated systolic hypertensionH R Black, W J Elliott, M A Weber, et al.
Controlled Clinical Trials|July 31, 1998
Rationale and design for the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) TrialH R Black, W J Elliott, J D Neaton, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
Clinical Therapeutics|September 18, 2001
Losartan versus valsartan in the treatment of patients with mild to moderate essential hypertension: data from a multicenter, randomized, double-blind, 12-week trialW J Elliott, D A Calhoun, P T DeLucca, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 8, 2000
Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working GroupG L Bakris, M Williams, L Dworkin, et al.
Circulation|March 1, 1990
Renal and hemodynamic effects of intravenous fenoldopam versus nitroprusside in severe hypertensionW J Elliott, R R Weber, K S Nelson, et al.
Hypertension (Dallas, Tex. : 1979)|November 17, 2001
One-year study of felodipine or placebo for stage 1 isolated systolic hypertensionH R Black, W J Elliott, M A Weber, et al.
Controlled Clinical Trials|July 31, 1998
Rationale and design for the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) TrialH R Black, W J Elliott, J D Neaton, et al.
Pageof 8